4th Symposium on Research and Innovation

The Oswaldo Cruz Institute (IOC/Fiocruz), a Brazilian organization that is world reference in health studies, will hold its fourth edition of the Symposium on Research and Innovation from April 9th to 11th. The theme of the event is ‘Innovative actions within scientific production’ and will be held at Fiocruz’s headquarters. Swissnex Brazil, in its mission to connect Switzerland and Brazil in the areas of Education, Research and Innovation, is an event partner and also promoted the presentation of three Swiss specialists: Gieri Cathomas, president of Swiss Healthcare startups; Daniela Brites, researcher at Swiss Tropical and Public Health Institute; and Raniero Pittini, director of Research Medtech at the Switzerland Innovation Park Biel/Bienne. Also in the program is the researcher Stephanie Morais, who was a participant at the 2018 edition of the Academia-Industry Training program.

On April 11th (6:30 p.m.), Dr. Daniela Brites will also present her work at the event HealthTalks@swissnex: Tuberculosis?, expanding discussions on the topic with other speakers at swissnex Brazil.

This edition of the Symposium aims to stimulate the debate on innovation and health at Fiocruz, an institution which is considered one of the largest centers of study and research in the sector in Latin America. The subject gained relevance after the regulation of the Innovation Law in 2018, which reduces administrative obstacles between the Brazilian public and private sectors in the area of ​​Science, Technology, and Innovation.

Collaboration between Fiocruz and swissnex Brazil in this event is one of the first actions envisioned in the Memorandum of Understanding signed between both institutions in November 2018. The initiative aims to bring Brazil and Switzerland closer in the areas of Life Sciences, HealthTech and Biotechnology in the academic field and also stimulate science-based innovation and entrepreneurship.

Swiss Lecturers:


Dr. Daniela Brites is a scientist at the Swiss Tropical and Public Health Institut in Basel, Switzerland. She is a biologist interested in understanding how the Mycobacterium tuberculosis complex evolves and how bacterial genetic diversity affects the clinical presentation of Tuberculosis using genomics and bioinformatics. Daniela will present the study on genetic characterization of Multi-Drug resistant Mycobacterium tuberculosis strains in Rio de Janeiro using whole-genome sequencing.

Dr. Raniero Pittini
Ph.D. in Physics from ETH Zürich with focus on magneto-optics and superconductivity. He has 10 years experience in academic research with more than 80 peer-reviewed articles; 5 years as assistant professor at Tohoku University (magnetism, optics, laser, nanostructures, spintronics); 17 years experience in the industry as technical executive, R&D director and innovation manager (electric motors, medical technologies, fiber optics). Dr. Raniero is Head of Research Medtech at Switzerland Innovation Park Biel/Bienne since 2017.

Dr. Gieri Cathomas is a medical doctor and studied at the University of Zurich and Humboldt University Berlin. Before initiating the Swiss Healthcare Startups Association, Gieri was founding and establishing several companies in the field of medical services, medical consulting and medical IT technology. He is also a lecturer at the Faculty of Medicine at the University of Zurich, where he is co-responsible for the module in Health Sector Management. Gieri is fluent in German, English, and Romansch.


Schedule (click to access the event website – Portuguese only)
Dates: April 09th, 10th and 11th- 2019
Venue: Emmanuel Dias Auditorium, Arthur Neiva Pavilion, Fiocruz – Rio de Janeiro.
Partners: FGV – NZTE – swissnex Brazil